Description: This session will cover lessons learned during the course of implementing PBR by the panelists. It will focus on areas that were difficult to interpret, unexpected issues and managing the process. It will focus on potential stumbling blocks from an implementation, pricing and product development standpoint. There will also be an overview of YRT treatment to date and an update on any emerging best practices.

Description: In this article, we explore key insights from Oliver Wyman's 2020 Life PBR Emerging Practices Survey, which provides a broad industry perspective with more than 50 companies participating representing 95 percent of the individual life market (by written premium). Insights include the impact of PBR on reserves and profitability in addition to emerging practices related to product design, assumption development, and methodology decisions.

Description: The valuation manual is a living document that continues to evolve. As more companies adopt Principle-Based Reserving (PBR) and file PBR Actuarial Reports, regulators have observed gaps and inconsistencies across the industry. As a result, PBR reporting requirements (VM-31) have expanded significantly in 2020 and still continue to evolve. This session will provide attendees with everything they need to fill out their PBR reports for both Life business and Variable Annuity business. We will dig into the new changes effective for 2020 reporting and approved changes for 2021, and compare and contrast the Life and VA requirements to help companies identify areas that can be leveraged between the two. In addition, we will share insights from regulators, consultants, and company actuaries on what to include or exclude in your report.

Description: This paper is presented as a means of explaining, in greater detail than was appropriate in its formal report, the methods used in the construction of the new standard ordinary mortality table, temporarily designated as Mortality Table X, and the corresponding experience mortality table, temporarily designated as Mortality Table X.

Description: This article summarizes the key changes to VM-31 requirements in the 2020 version of the Valuation Manual for both life and variable annuities, and compares and contrasts the requirements for each. In addition, the article offers insights into common issues and recommendations for VM-31 reports from the viewpoints of a regulator, consultant, and company actuary.

Description: This session at the SOA 2001 Annual Meeting presents issues with the implementation of Regulation XXX including X-factor certification, development of an actuarial guideline for XXX, issues with certain policy designs, and UL products with prefunding of guarantees.

Description: 1998 Valuation Actuary Symposium. This session about strengthening reserves based on cash-flow testing provided some practical solutions to reserve-strengthening issues using reinsurance and a look at the issue from a small company perspective.

Description: This is a discussion of the paper, 'The New Standard Ordinary Mortality Table' paper by Sternhell.

Description: In November 2020 the Life Actuarial (A) Task Force unanimously passed APF 2020-08 which adds a third permissible method in the Valuation Manual to determine company experience mortality rates. This article describes the three methods